Has Andrew Decker, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,946 in general payments to Andrew Decker, MD across 20 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Andrew Decker, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Andrew Decker, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Andrew Decker, MD

Neurology · White Plains, NYNPI 1265547236

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,230 of the $1,946 with a category attached, or 63.2%. 12 manufacturers reported payments, led by Biogen at 29.5% of the total. Reporting peaked in 2021 at $620 and has fallen 57.1% since, to $266 in 2025.

$1,946in general payments, 2019–2025

Across 20 payments — averaging $97.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Biogen$575
Viz.ai, Inc.$335
Genentech USA, Inc.$240
Sanofi$240
Medtronic$202
Eisai Inc.$125
plus $229 from 6 others

What the payments were for

Consulting fees$45023%
Speaking & faculty fees$24012%
Food & beverage$1,23063%
Education$261%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Biogen	4	$575
Viz.ai, Inc.	1	$335
Genentech USA, Inc.	2	$240
Sanofi	1	$240
Medtronic	2	$202
Eisai Inc.	1	$125
Bristol Myers Squibb	2	$73
Lundbeck LLC	2	$55
AbbVie	1	$44
EMD Serono, Inc.	2	$26
E.r. Squibb & Sons, L.L.C.	1	$16
Novartis	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,946 in reported general payments places this provider in the 60th percentile of 1,623 neurology providers in New York.

See all neurology providers in New York →

Medicare billing

Part B allowed, 2024

$190,100

Medicare patients

673

Services billed

2,365

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Gamunex-CImmune Globul G/Gly/Iga Avg 46	32	$665,478
GammakedImmune Globul G/Gly/Iga Avg 46	14	$373,871
Kesimpta PenOfatumumab	12	$95,749
IngrezzaValbenazine Tosylate	13	$91,198
MestinonPyridostigmine Bromide	11	$45,399
Dimethyl Fumarate	27	$44,985
Pyridostigmine Bromide	18	$39,250
Rivastigmine	80	$19,181
Memantine Hcl	251	$15,035
MyrbetriqMirabegron	15	$14,926
Donepezil Hcl	738	$12,021
Memantine Hcl ErMemantine Hcl	39	$8,217
Enoxaparin Sodium	11	$7,772
Rasagiline Mesylate	28	$7,357
Pregabalin	140	$5,995

Paid to pharmacies, not to this prescriber.

Other neurology in White Plains

Idan SharonBrooklyn$2.1M
Allan PerelStaten Island$1.7M
Nicolas SaikaliAmherst$1.5M
David KreitzmanCommack$1.5M
Charles ArgoffAlbany$1.2M
Stephen KriegerNew York$1.1M
Robert FeketeHawthorne$1M
Jennifer McVigeAmherst$982K
Warren SpinnerPort Jefferson Station$791K
Richard LiptonBronx$753K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →